- Home
- ARAY
ARAY
Accuray Incorporated
as 10-07-2025 3:30pm EST
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
| Founded: | 1990 | Country: | United States |
| Employees: | N/A | City: | MADISON |
| Market Cap: | 170.1M | IPO Year: | 2007 |
| Target Price: | $5.00 | AVG Volume (30 days): | 740.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.02 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.14 - $2.95 | Next Earning Date: | 11-05-2025 |
| Revenue: | $458,505,000 | Revenue Growth: | 2.68% |
| Revenue Growth (this year): | 5.84% | Revenue Growth (next year): | 3.90% |
Latest Accuray Incorporated News
ARAY Breaking Stock News: Dive into ARAY Ticker-Specific Updates for Smart Investing
Just Food
2 days ago
Clarebout Potatoes’ staff strike over bonuses linked to JR Simplot takeover
Business Wire
2 days ago
Diamond Chemical Announces Appointment of New CEO
Insider Monkey
2 days ago
Is this the Best Time to Add Parker-Hannifin (PH)?
CNW Group
2 days ago
FSRA issues Notice of Proposal against Daumier Financial Services Inc. o/a Daumier Financial Services Ltd., Carlos Daumier De Zayas Benitez, and Liset Jimenez Rodriguez
MT Newswires
2 days ago
UBS Adjusts Price Target on Chemours to $21 From $17, Maintains Buy Rating
Euronews
2 days ago
‘When people buy an EV, they rarely go back’: Hyundai CEO on designing for Europe
MT Newswires
2 days ago
UBS Adjusts Price Target on Graphic Packaging Holding to $20 From $24, Maintains Neutral Rating
MT Newswires
2 days ago
UBS Adjusts Price Target on Ecolab to $299 From $295, Maintains Neutral Rating
Compare ARAY vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ARAY Accuray Incorporated - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.